申请人:Paone Daniel Vincent
公开号:US20100298303A1
公开(公告)日:2010-11-25
The present invention is directed to compounds of Formula I:
and Formula II:
(where variables R
1
, R
2
, R
3
, R
4
, A, B, G, J, Q, T, U, V, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
本发明涉及式I和式II的化合物:(其中变量R1,R2,R3,R4,A,B,G,J,Q,T,U,V,W,X和Y如本文所定义),其作为CGRP受体拮抗剂在治疗或预防CGRP参与的疾病,如头痛、偏头痛和集群头痛中具有用途。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗CGRP参与的这些疾病中使用这些化合物和组合物的用途。